Oxaliplatin Kabi

Oxaliplatin, the active ingredient in Oxaliplatin Kabi, is a platinum-based chemotherapy presented as a injection for intravenous use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Oxaliplatin Kabi is used primarily for colorectal cancer treatment pathways and its clinical use includes: - Colorectal cancer: Enhances the efficacy of combination chemotherapy regimens. - Gastric cancer: Contributes to tumour shrinkage when used in mult‑ drug protocol S . - Pancreatic and biliary cancers : Provides additional cytotoxic activity in combination therapies . - Advanced t ​     ​  ​  ​  ​  ​  ​  ​   ​  ​   ​  ​ -  …  …  …  …  …  …  …  …  …  … …  ...  …  …  … -  … … … … … … … … … … … … …  …  …  … - … … … … … …  …  ...

Oxaliplatin Kabi may … … … ... 

Common Side Effects: -    ...  ....  … … … … … … … … … … … … …  - … … … … … … … … … ...  - … … the … … ...

Ox‑